These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8895991)

  • 21. [Environmental carcinogens and p53 gene mutation].
    Xu Z; Jin Y
    Wei Sheng Yan Jiu; 2004 Mar; 33(2):239-43. PubMed ID: 15209018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin B1-related hepatocellular carcinoma.
    Long XD; Zhao D; Wang C; Huang XY; Yao JG; Ma Y; Wei ZH; Liu M; Zeng LX; Mo XQ; Zhang JJ; Xue F; Zhai B; Xia Q
    Epidemiology; 2013 Sep; 24(5):671-81. PubMed ID: 23788213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The genetics of human cancer: implications for ecotoxicology.
    McMahon G
    Environ Health Perspect; 1994 Dec; 102 Suppl 12(Suppl 12):75-80. PubMed ID: 7713039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity.
    Kirk GD; Turner PC; Gong Y; Lesi OA; Mendy M; Goedert JJ; Hall AJ; Whittle H; Hainaut P; Montesano R; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):373-9. PubMed ID: 15734960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular dosimetry of aflatoxin DNA adducts in humans and experimental rat models.
    Groopman JD; Roebuck BD; Kensler TW
    Prog Clin Biol Res; 1992; 374():139-55. PubMed ID: 1320272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aflatoxin and hepatocellular carcinoma: a useful paradigm for environmentally induced carcinogenesis.
    Kolars JC
    Hepatology; 1992 Sep; 16(3):848-51. PubMed ID: 1324219
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatocellular carcinoma--carcinogenesis updated.
    Yap I
    Singapore Med J; 1995 Dec; 36(6):597-9. PubMed ID: 8781628
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatocellular carcinoma and vinyl chloride.
    Mastrangelo G; Fedeli U; Martines D
    Cancer Causes Control; 2009 May; 20(4):505-6; author reply 507-8. PubMed ID: 19039674
    [No Abstract]   [Full Text] [Related]  

  • 29. Geographic variation of p53 mutational profile in nonmalignant human liver.
    Aguilar F; Harris CC; Sun T; Hollstein M; Cerutti P
    Science; 1994 May; 264(5163):1317-9. PubMed ID: 8191284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
    Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is aflatoxin carcinogenic in man? The evidence in Swaziland.
    Keen P; Martin P
    Trop Geogr Med; 1971 Mar; 23(1):44-53. PubMed ID: 4324784
    [No Abstract]   [Full Text] [Related]  

  • 32. [A case-control study on the association of hepatocellular carcinoma with genetic polymorphisms of CYP3A5 in a highly aflatoxin B1 contaminated Guangxi area].
    Lu HX; Feng ZB; Feng XL
    Zhonghua Gan Zang Bing Za Zhi; 2007 Sep; 15(9):705-6. PubMed ID: 17903382
    [No Abstract]   [Full Text] [Related]  

  • 33. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.
    Hussain SP; Schwank J; Staib F; Wang XW; Harris CC
    Oncogene; 2007 Apr; 26(15):2166-76. PubMed ID: 17401425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [p53 gene mutation in hepatocellular carcinoma].
    Jiang W; Lu Q; Pan G
    Zhonghua Wai Ke Za Zhi; 1998 Sep; 36(9):531-2. PubMed ID: 11825456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aflatoxins as a risk factor for hepatocellular carcinoma in Egypt, Mansoura Gastroenterology Center study.
    Abdel-Wahab M; Mostafa M; Sabry M; el-Farrash M; Yousef T
    Hepatogastroenterology; 2008; 55(86-87):1754-9. PubMed ID: 19102385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of hepatocellular carcinoma in nonhuman primates by chemical carcinogens.
    Adamson RH
    Cancer Detect Prev; 1989; 14(2):215-9. PubMed ID: 2559797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The light at the end of the tunnel for chemical-specific biomarkers: daylight or headlight?
    Groopman JD; Kensler TW
    Carcinogenesis; 1999 Jan; 20(1):1-11. PubMed ID: 9934843
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of the expression of beta-catenin in hepatocellular carcinoma in areas with high and low levels of exposure to aflatoxin B1.
    Chen Ban K; Singh H; Krishnan R; Fong Seow H
    J Surg Oncol; 2004 Jun; 86(3):157-63. PubMed ID: 15170655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 249ser p53 mutation in the serum of black southern African patients with hepatocellular carcinoma.
    Kimbi GC; Kew MC; Yu MC; Arakawa K; Hodkinson J
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1185-90. PubMed ID: 16048565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular aspects of hepatocellular carcinoma].
    Moradpour D; Blum HE
    Zentralbl Chir; 2000; 125(7):592-6. PubMed ID: 10960967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.